A Clinical trial to study the effect of Erandbeejadi vati in Rheumatoid Arhtritis(Amavata)

A Single Arm Clinical Study To Evalute The Efficacy Of Erandbeejadi Vati In The Management of Amavata With Special Reference To Rheumatoid Arthritis. - RA

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082419

Enrollment

Registered

2025-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1-Subjects willing to sign the consent forms. 2-Subjects in the age group between 20-70 year. 3-Either sex. 4-New cases of RA. 5-Subjects having sandhishool,sandhishoth,sandhistsbdhata,sparshaasahatva and associated lakshnas of amavata. 6-Chronicity should be less than 3 year.

Exclusion criteria

Exclusion criteria: 1-Subject on standard treatment. 2-Subjects in the age group of less than 20 years and more than70 year will not be included for the present study. 3-Subjects having major illness and prediagnosed of Hypertension,HIV,Diabetes mellitus,Rheumatic fever were excluded from the study. 4-Deformity like swan neck,Boutonniere,Hitchhiker.

Design outcomes

Primary

Measure	Time frame
Reduction in sign and symptoms of Rheumatoid arthritis.Timepoint: 45 days	—

Secondary

Measure	Time frame
1-Cost effective treatment. 2-To observe if there any side effect.Timepoint: 45 days	—

Countries

India

Contacts

Public ContactDr Bandana dhall

Kunwar shekhar vijendra ayurved medical college and research centre gangoh

bandanadhall1981@gmail.com9348061460

Outcome results